Changes of proapoptotic and antiapoptotic genes affect sensitivity to apoptotic stimuli in impaired contractility due to long term bladder outlet obstruction

• Published in: PloS one 2022-12, Vol.17 (12), p.e0279503-e0279503
• Main Authors: Kim, Jae Heon, Yang, Hee Jo, Choi, Sung Sik, Lee, Hong J, Song, Yun Seob
• Format: Article
• Language: English
• Subjects: Abdomen; Analysis; Anesthesia; Animals; Antibodies; Apoptosis; Arrays; Bcl-2 protein; Biological activity; Biology and Life Sciences; Bladder; Catheters; Cell differentiation; Differentiation (biology); Disease Models, Animal; Female; Gene expression; Genes; Interleukin 10; Interleukin-10 - metabolism; Ischemia; Laboratory animals; Medicine and Health Sciences; Metabolism; Molecular modelling; Muscle contraction; Muscles; Myocytes, Smooth Muscle - metabolism; p53 Protein; Pain; Physiology; Proteins; Rats; Rats, Sprague-Dawley; Research and Analysis Methods; Sensitivity; Smooth muscle; Stat3 protein; Stimuli; Sutures; Tumor necrosis factor; Urinary Bladder - metabolism; Urinary Bladder Neck Obstruction - genetics
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0279503

The normal biological process that necessitates cell removal greatly depends on apoptosis. Long term bladder outlet obstruction (BOO) causes damaged smooth muscle cells to undergo apoptosis. However, smooth muscle cell apoptosis that BOO causes is not well known in impaired bladder contractility. Therefore, we designed this study to investigate whether long-term BOO could induce apoptosis activities and to obtain an expression profile of apoptosis related genes. We used 10 Sprague-Dawley six-week-old female rats. We separated them equally into two groups: a sham intervention group (group 1) and an eight-week BOO group (group 2). We conducted cystometric evaluation eight weeks following BOO onset, with processing of bladder tissue for PCR array. Every array comprised 84 genes, which were established to contribute to an apoptosis response, cell differentiation and metabolism, and 12 sequences were established for the regulation of loading and the quality of cDNA. We performed real-time PCR. Changes in gene expression presented as a fold increase/decrease. Alterations of more than two-fold constituted the cut-off determining expression. Group 2 had a greater bladder weight and Impaired bladder contractility. Immunofluorescent staining with CAS3, TUNEL showed increased in the BOO group. In comparison to group 1, group 2 exhibited an at least two-fold upregulation in five genes, the Bcl-2 (15.1), Birc5 (5.8), Cd40lg (7.5), Il10 (16.2), and Naip2 (13.2). They also demonstrated at least a two-fold downregulation in the PRLR (-18.1) gene. Genes Bcl2ald, Circ5, Cd40lg, Il10, Naip2, and PRLR were among the genes with activity against apoptosis. TNF, STAT3 and TP53 mediated the effect that genes had on one another. This study demonstrated that the relative ratios of pro- and antiapoptotic genes determine bladder cell sensitivity cells to apoptotic stimuli in impaired contractility caused by long term BOO. Although we cannot confirm whether this finding is the result of the decompensated phase of the bladder or the process, the gene expression profiles could explain molecular mechanisms of apoptosis in impaired bladder contractility caused by long-term BOO with further studies.